Kaltsonoudis, E., Pelechas, E., Voulgari, P. V., & Drosos, A. A. (2019). Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study. J Clin Med.
Παραπομπή Chicago StyleKaltsonoudis, Evripidis, Eleftherios Pelechas, Paraskevi V. Voulgari, και Alexandros A. Drosos. "Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched From Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study." J Clin Med 2019.
Παραπομπή MLAKaltsonoudis, Evripidis, Eleftherios Pelechas, Paraskevi V. Voulgari, και Alexandros A. Drosos. "Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched From Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study." J Clin Med 2019.